Genetic defects underlying the melanocortin-4 receptor (MC4R) signaling pathway lead to severe obesity. Three severely obese LEPR-deficient individuals were administered the MC4R agonist setmelanotide, resulting in substantial and durable reductions in hyperphagia and body weight over an observation period of 45–61 weeks. Compared to formerly developed and tested MC4R agonists, setmelanotide has the unique capability of activating nuclear factor of activated T cell (NFAT) signaling and restoring function of this signaling pathway for selected MC4R variants. Our data demonstrate the potency of setmelanotide in treatment of individuals with diverse MC4R-related pathway deficiencies.
Subscribe to Journal
Get full journal access for 1 year
only $18.75 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Farooqi, I. S. & O’Rahilly, S. J. Endocrinol. 223, T63–T70 (2014).
Krishna, R. et al. Clin. Pharmacol. Ther. 86, 659–666 (2009).
Farooqi, I. S. et al. N. Engl. J. Med. 341, 879–884 (1999).
Clément, K. et al. Nature 392, 398–401 (1998).
Jackson, V. M., Price, D. A. & Carpino, P. A. Expert Opin. Investig. Drugs 23, 1055–1066 (2014).
Kühnen, P. et al. N. Engl. J. Med. 375, 240–246 (2016).
Farooqi, I. S. et al. N. Engl. J. Med. 356, 237–247 (2007).
Huvenne, H. et al. J. Clin. Endocrinol. Metab. 100, E757–E766 (2015).
Bischof, J. M., Van Der Ploeg, L. H., Colmers, W. F. & Wevrick, R. Br. J. Pharmacol. 173, 2614–2621 (2016).
Collet, T. H. et al. Mol. Metab. 6, 1321–1329 (2017).
Gantz, I. et al. J. Biol. Chem. 268, 15174–15179 (1993).
Ghamari-Langroudi, M. et al. Nature 520, 94–98 (2015).
Yang, L. K. & Tao, Y. X. Biochim. Biophys. Acta 1863, 2486–2495 (2017).
Li, Y. Q. et al. J. Clin. Invest. 126, 40–49 (2016).
Ollmann, M. M. et al. Science 278, 135–138 (1997).
Büch, T. R., Heling, D., Damm, E., Gudermann, T. & Breit, A. J. Biol. Chem. 284, 26411–26420 (2009).
Stutzmann, F. et al. Diabetes 57, 2511–2518 (2008).
Dinter, J. et al. J. Mol. Endocrinol. 54, 205–216 (2015).
Tarnow, P., Schoneberg, T., Krude, H., Gruters, A. & Biebermann, H. J. Biol. Chem. 278, 48666–48673 (2003).
Rasmussen, S. G. et al. Nature 477, 549–555 (2011).
Hanson, M. A. et al. Science 335, 851–855 (2012).
Koehbach, J. et al. Proc. Natl Acad. Sci. USA 110, 21183–21188 (2013).
Ericson, M. D. et al. Biochim. Biophys. Acta 1863, 2414–2435 (2017).
We thank D. Schnabel for his support and A. Stielow, S. Zvorc, S. Jyrch, and C. Cetindag (Charité Universitätsmedizin Berlin, Germany) and H. Guermoudi, V. Lemoine and F. Marchelli (Pitié-Sapêtrière hospital, Paris, France) for excellent study assistance. This work was supported by grants from the German Research Foundation (DFG) (KU 2673/2-1; SPP1629: BI839/5-2, KR1701/5-1; KFO218 and HI 865/2-1), Bundesministerium für Bildung und Forschung (BMBF) (NGFN- Plus, 01GS0820), the Helmholtz Association (ICEMED) (WB19) and the Institute of Cardiometabolism and Nutrition (K.C.) as well as Assistance Publique Hôpitaux de Paris (clinical research contracts to K.C. and C.P.) and Institut Benjamin Delessert. P.K. was supported by the Charité /Berlin Institute of Health (BIH) Clinical Scientist Program. H.K. and K.M. were supported by the Berlin Institute of Health (BIH). P.S. was supported by the DFG (SFB740-B6, SFB1078-B6), and G.K. and P.S. were supported by the DFG Cluster of Excellence ‘Unifying Concepts in Catalysis’ (Research Field E). I.S.F. was supported by the Wellcome Trust.
L.V.d.P., F.F. and K.G. are employees and stock holders of Rhythm Pharmaceuticals. S. Sharma is a consultant for Rhythm Pharmaceuticals.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Clément, K., Biebermann, H., Farooqi, I.S. et al. MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency. Nat Med 24, 551–555 (2018). https://doi.org/10.1038/s41591-018-0015-9
Current Obesity Reports (2020)
Genetic Causes of Severe Childhood Obesity: A Remarkably High Prevalence in an Inbred Population of Pakistan
Pratiques en nutrition (2020)
Rare Variants in Genes Linked to Appetite Control and Hypothalamic Development in Early-Onset Severe Obesity
Frontiers in Endocrinology (2020)
<p>Converging Relationships of Obesity and Hyperuricemia with Special Reference to Metabolic Disorders and Plausible Therapeutic Implications</p>
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy (2020)